6,257 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Purchased by Virtu Financial LLC

Virtu Financial LLC bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 6,257 shares of the company’s stock, valued at approximately $248,000.

Several other hedge funds also recently modified their holdings of the business. Lindbrook Capital LLC lifted its holdings in Acadia Healthcare by 1,342.0% in the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. lifted its stake in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after purchasing an additional 345 shares during the period. Nisa Investment Advisors LLC boosted its position in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares during the last quarter. Signaturefd LLC increased its holdings in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp increased its holdings in Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after purchasing an additional 454 shares during the last quarter.

Analysts Set New Price Targets

Several research firms have recently issued reports on ACHC. Bank of America decreased their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Mizuho lowered their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research note on Tuesday. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. TD Cowen lowered their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Stock Performance

ACHC opened at $30.12 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market capitalization of $2.80 billion, a price-to-earnings ratio of 9.88, a P/E/G ratio of 1.46 and a beta of 1.38. The business’s 50-day moving average price is $37.14 and its two-hundred day moving average price is $45.28. Acadia Healthcare Company, Inc. has a 1 year low of $27.61 and a 1 year high of $82.41.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.